Showing results (151-160 of 158) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 158 results.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 26, 2017
[Indoleamine 2,3-Dioxygenase Activity during Fulvestrant Therapy for Aromatase Inhibitor Resistant Metastatic Breast Cancer]Kenichi Sakurai, Shigeru Fujisaki, Hitomi Kubota, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 23, 2015
[Indoleamine 2,3-Dioxygenase Activity during I131-Radioisotope Therapy for Metastatic Thyroid Cancer]Kenichi Sakurai, Shigeru Fujisaki, Keita Adachi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 26, 2016
[Usefulness of Local Therapy in Elderly Breast Cancer Patients with Distant Metastases]Kenichi Sakurai, Shigeru Fujisaki, Shuhei Suzuki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 26, 2016
[Interval Breast Cancer with Neuroendocrine Differentiation]Kenichi Sakurai, Shigeru Fujisaki, Keita Adachi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 2, 2018
[Treatment Experience of Palbociclib as a New Checkpoint Inhibitor]Kenichi Sakurai, Shigeru Fujisaki, Hitomi Kubota, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 14, 2018
[Asynchronous Bilateral Neuroendocrine Breast Carcinoma - A Case Report]Kaori Abe, Satoshi Mori, Yumi Koyama, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 26, 2017
[Clinical Evaluation of Immunosuppressive Acidic Protein in the Serum of Patients with Inflammatory Breast Recurrence]Hironori Goto, Kenichi Sakurai, Shigeru Fujisaki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 23, 2015
[Indoleamine 2,3-Dioxygenase Activity during Fulvestrant Therapy for Aromatase Inhibitor-Resistant Metastatic Breast Cancer]Kenichi Sakurai, Shigeru Fujisaki, Shuhei Suzuki, et al.
Pageof 16